Company Founder and Chief Executive Officer: Kim K. Thompson
Mr. Thompson received his B.A. in Applied Economics from James Madison College at Michigan State University. He received his Juris Doctorate from the University of Michigan Law School.
Kim Thompson invented the spider silk production platform and founded Kraig Biocraft Laboratories in his pursuit of the development of new biotechnologies with industrial applications. The Company was founded to develop this spider silk technology and reduce it to practice in collaboration with leading university scientists.
Mr. Thompson brings a wealth of experience in business management and consultation to Kraig. Following the completion of his undergraduate degree, Mr. Thompson joined California Craftsman, Inc. as a Vice-President with primary responsibility for both financial operations and marketing.
Kim Thompson was the director of business development at Franchise Venture Partners, LLC. He subsequently joined the firm of Shearson, Lehman, Hutton where he specialized in equity trading and research of small-cap companies. His experience in those small-cap equity markets has proven to be invaluable both in his legal and business successes.
Prior to founding Kraig, Mr. Thompson was the founder and senior litigation partner in a successful California commercial law firm where he worked as corporate and litigation counsel to privately held and public companies. His many accomplishments in corporate law include winning and collecting in full what his firm believes to have been the largest award of lost profits in a California commercial arbitration up to that time. An important part of his work was winning victories on behalf of corporate clients in disputes over intellectual property and distribution rights. He has represented business clients ranging from small start-ups and micro-caps to Fortune 100 companies.
With a background in business leadership and in advising public and private corporations, Kim Thompson continues to bring a unique perspective to the successful management of the Company. His extensive business and legal background enables him to create practical solutions to business problems and seize opportunities for growth.
Mr. Thompson is a member of the Triple Nine Society for persons with documented genius level IQs (having tested above the 99.9th percentile). He is active in the realm of science and invention where he has to his credit a number of provisional patent applications, including innovations in the areas of biotechnology, organic polymers, genetic engineering and magnetic field manipulation, among others.
Chief Operations Officer: Jon R. Rice
Mr. Rice has over 13 years’ experience growing development stage businesses with a focus on technology development, commercialization, and go to market strategies. Mr. Rice holds a B.S. in Chemical engineering from Michigan Technological University and a Masters of Business Administration from the Eli Broad College of Business: Michigan State University.
Prior to joining Kraig Biocraft Laboratories Mr. Rice was the Director of Advanced Technologies for Ultra Electronics, AMI. In this role, Mr. Rice was responsible for the identification, capture, and execution of new technology programs. During his tenure with AMI, Rice secured more than twenty five million dollars in funded development programs from the US Department of Defense which his team successfully leveraged into commercially viable spinoff products. Mr. Rice was also responsible for technical sales, marketing, and promotion of AMI’s products and capabilities. Rice joined AMI as the third full time employee and helped to lead the organization through its rapid growth and ultimate acquisition by Ultra Electronics in 2011.
Earlier in his career Mr. Rice developed unique advanced manufacturing techniques, established and trained a production staff, led engineering development, authored numerous technical papers, and is a recognized subject matter expert. Mr. Rice holds 5 issued patents and numerous provisional patents.
Mr. Rice brings a history of transforming revolutionary ideas into viable commercial products.
BOARD OF SCIENTIFIC ADVISORS
MALCOLM J. FRASER, JR. PH.D.
Dr. Fraser received his Ph.D. from Ohio State University, and performed postdoctoral research at both Penn State University and Texas A & M University. At Texas A & M he was a part of the team which developed the genetic expression system which is now a widely used methodology for producing organic molecules, including pharmaceuticals, on an industrial scale.
He is the co-inventor of the gene splicing technology “piggyBac”, as well as the inventor of various piggyBac improvement patents. It was his work on piggyBac which first caught the attention of Kraig Biocraft Laboratories.
He was recently selected as a fellow of the American Association for the Advancement of Science. This was awarded in recognition for his distinguished contributions to genetics and transgenesis, and for his discovery of the piggyBac transposable element and derived transgenic vector system.
In 2006, Dr. Fraser was awarded $2.5 million from the Bill and Melinda Gates Foundation to fund “deliverable technologies” in the field of transgenesis, for the prevention of mosquito born disease.
Dr. Fraser is a member of the faculty at the University of Notre Dame, where he heads the Fraser Laboratory. The focus of his work is molecular genetics. He is the author or co-author of numerous scientific articles in the field of genetic engineering and gene manipulation.
Dr. Fraser is also the co-author of the famous peer reviewed science journal PNAS (the Journal of the National Academy of Sciences). In which Dr. Fraser describes his work in creating genetically engineered spider silk. Kraig was a sponsor and collaborator in that work.
DONALD L. JARVIS, PH.D.
Dr. Jarvis received his B.S. and M.S. in microbiology at Idaho State University and his Ph.D. in Virology at Baylor College of Medicine.
He heads a research laboratory within the University’s of Wyoming’s Department of Molecular Biology which focuses on biochemistry and biosynthesis.
BUSINESS ADVISORY BOARD
Henry Wendt is the former CEO and Chairman of SmithKline Beecham, one of the world’s largest and most successful corporations. He has an unparalleled track record for fostering and managing corporate growth through mergers and acquisitions, as well as through organic growth and global marketing. In fact, he is generally recognized as the principal architect of the successful merger that created SmithKline Beecham.
In his term as CEO of the pharmaceutical giant, Wendt focused on a “3 point strategy” to help strengthen the business. His strategy consisted of increasing support of SmithKline’s best products, such as Tagamet, weeding out less profitable products, and increasing shareholder value. This strategy lead to the successful merger of SmithKline with UK-based Beecham Company. The creation of SmithKline Beecham (SKB), engineered by Wendt and Beecham’s chief, created the world’s second largest pharmaceutical company in both prescription and over-the-counter drugs.
In addition to his groundbreaking leadership at SmithKline Beecham, Mr. Wendt literally wrote the book on successful strategies for corporate growth in the global marketplace, Global Embrace: Corporate Challenges in a Transnational World, a ‘must read’ for corporate executives.
Mr. Wendt is the Co-Founder of Healthcare Investment Partners, as well as the Founder of Global Health Care Partners. He is a graduate of Princeton University.
Raymond Kutsunai’s unique accomplishments and lifetime experiences have enabled him to forge a path that has left his mark on history and international business.
Mr. Kutsunai grew up in pre-statehood Hawaii, the geographical and cultural hub that links North America and Asia. When he was a teenager he was sent to Hiroshima to study Japanese and renew his family and cultural ties. Unfortunately, this was just prior to the outbreak of the Second World War. He attended high school in Hiroshima. Unable to return to Hawaii during the war, he attended university in Japan.
Immediately after the war, Mr. Kutsunai was distinctively positioned to assist both the United States and the people of Japan. Upon his homecoming to the United States, Mr. Kutsunai returned to school and completed his university degree at the University of Michigan.
Mr. Kutsunai subsequently rose rapidly through the ranks at SmithKline & French and was named General Manager of SmithKline & French Laboratories Japan. He was able to parlay his business instincts and extensive understanding of the Japanese culture and business environment into stunning successes for the Company’s Japanese operations.
As remarkable as Mr. Kutsunai’s incredible personal and professional experiences have been, they are exceeded by his loyalty to his family, friends, associates and country.
JOE CUNNING, PH.D.
Dr. Joe Cunning is a leading figure in the textile industry and member of the Textile Institute’s governing board, with 45 years of experience in the fibers, textile and apparel industry. He was awarded the Textile Institute’s Medal for outstanding contribution to the industry in 2000. In 2010 he was presented with the Textile Institute’s Companion Membership award, as one of fifty living persons who have made a significant impact on the textile industry.
Dr. Cunning completed a highly successful 28 year career at DuPont, where he headed the pioneering research laboratory in Wilmington, and was in charge of worldwide research on all fiber types. His manufacturing experience included worldwide responsibility for non-woven products, as well as polyester filament and staple fibers.
In addition to his work on various corporate boards, Dr. Cunning served on the governing boards of the Fiber Society, vice-president of the Textile Institute, the Technical Advisory Committee, and on the board of governors of the Iowa State University Foundation. In 1992, Cunning was named the National Textile Center ‘s (a research consortium of eight universities) first Executive Director, a post he held for 12 years. Dr. Cunning is also the President of Cunning & Associates, Ltd., a leading textile industry consulting firm.
By clicking on the links above, you will be leaving Kraig’s website. Please note that KBLB does not control and is not responsible for the content on such sites.